08.12.26 -- Tariffs, FDA Chaos, And BioSecure: How CDMOs Should Operate

Aligning compounding operations with USP <797> and <800> requires an integrated control strategy. Explore key criteria for cleanroom equipment selection. 

Discover strategies to calibrate testing scope to risk, optimize execution workflows, and reduce operational burdens without compromising quality standards or safety compliance.

EU GMP Annex 1 now defines clear expectations for glove integrity testing. Examine how reliability, efficiency, and equipment usability are becoming essential factors for maintaining compliance.

Gain insight into a connected approach to pharmaceutical development that links R&D, manufacturing, and supply chain operations to improve visibility, speed, and quality.

Improve workflow coordination across lab systems with better visibility, automated decision logic, audit-ready traceability, and repeatable processes that help teams move work more efficiently.

Read how leading IDS pharmacies are using remote monitoring workflows and digital accountability systems to improve accuracy, reduce site burden, and maintain audit readiness.

Prepare for the upcoming USP <788> revisions by strengthening your particulate control strategy to support regulatory compliance, product quality, and patient safety across injectable drug products.

Next-generation sequencing technologies and workflow automation are accelerating genomic research. Understand the key differences between sequencing methods and uncover strategies to boost efficiency.

AI is reshaping consent materials, but accuracy, oversight, and transparency remain essential. As guidance evolves, organizations must balance innovation with accountability to protect participants.

Effective cleanroom management requires moving beyond checkbox compliance. Learn how to empower your workforce by connecting individual roles to broader contamination control goals and behaviors.

Explore essential conceptual design principles for transforming alternative spaces into efficient, regulatory-aligned cleanroom environments for your critical processes.

Ensuring consistency and quality at every manufacturing stage is critical for CRISPR-Cas gene editing. To achieve this, the FDA recommends establishing well-defined acceptance criteria for RNP formation.

Policy and scientific validation have aligned to shift drug development beyond animal models. New regulations and technologies are making human‑relevant methods the standard for preclinical research.